| Literature DB >> 36181621 |
Tatsuaki Sumiyoshi1, Kenichiro Uemura2, Ryuta Shintakuya1, Kenjiro Okada1, Hiroyuki Otsuka1, Masahiro Serikawa3, Yasutaka Ishii3, Tomofumi Tsuboi3, Koji Arihiro4, Shinya Takahashi1.
Abstract
The standard chemotherapy for patients with unresectable cholangiocarcinoma is gemcitabine plus cisplatin, and gemcitabine plus S-1 (GS) chemotherapy is also reported to have similar effectiveness in Japan. However, the response rates of these two chemotherapies were modest, and no patients with intrahepatic cholangiocarcinoma (ICC) have shown a pathological complete response (pCR) following these chemotherapies. We report here the first case of an initially unresectable locally advanced ICC that achieved pCR following GS chemotherapy.Entities:
Keywords: Gemcitabine; Intrahepatic cholangiocarcinoma; Pathological complete response; S-1
Year: 2022 PMID: 36181621 DOI: 10.1007/s12328-022-01700-x
Source DB: PubMed Journal: Clin J Gastroenterol ISSN: 1865-7265